146 related articles for article (PubMed ID: 36813599)
1. Associated oral manifestations with HIV southeastern Brazilian patients on antiretroviral therapy.
Lustosa de Souza BK; Faé DS; Lemos CAA; Verner FS; Machado RA; Ortega RM; de Aquino SN
Braz J Otorhinolaryngol; 2023; 89(3):425-431. PubMed ID: 36813599
[TBL] [Abstract][Full Text] [Related]
2. Oral manifestations of HIV in a southeast USA population.
Patton LL; McKaig RG; Strauss RP; Eron JJ
Oral Dis; 1998 Sep; 4(3):164-9. PubMed ID: 9972166
[TBL] [Abstract][Full Text] [Related]
3. Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults.
Chattopadhyay A; Caplan DJ; Slade GD; Shugars DC; Tien HC; Patton LL
Community Dent Oral Epidemiol; 2005 Feb; 33(1):35-44. PubMed ID: 15642045
[TBL] [Abstract][Full Text] [Related]
4. HIV infection: oral lesions, CD4+ cell count and viral load in an Italian study population.
Margiotta V; Campisi G; Mancuso S; Accurso V; Abbadessa V
J Oral Pathol Med; 1999 Apr; 28(4):173-7. PubMed ID: 10235371
[TBL] [Abstract][Full Text] [Related]
5. Oral manifestations of HIV infection by gender and transmission category in Mexico City.
Ramirez-Amador V; Esquivel-Pedraza L; Sierra-Madero J; Ponce-de-Leon S; Ponce-de-Leon S
J Oral Pathol Med; 1998 Mar; 27(3):135-40. PubMed ID: 9563806
[TBL] [Abstract][Full Text] [Related]
6. Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in northern and southern Thai patients.
Kerdpon D; Pongsiriwet S; Pangsomboon K; Iamaroon A; Kampoo K; Sretrirutchai S; Geater A; Robison V
Oral Dis; 2004 May; 10(3):138-44. PubMed ID: 15089922
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy.
Kroidl A; Schaeben A; Oette M; Wettstein M; Herfordt A; Häussinger D
Eur J Med Res; 2005 Oct; 10(10):448-53. PubMed ID: 16287607
[TBL] [Abstract][Full Text] [Related]
8. Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS).
Greenspan D; Komaroff E; Redford M; Phelan JA; Navazesh M; Alves ME; Kamrath H; Mulligan R; Barr CE; Greenspan JS
J Acquir Immune Defic Syndr; 2000 Sep; 25(1):44-50. PubMed ID: 11064503
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for oral hairy leukoplakia in HIV-infected adults of Brazil.
Moura MD; Grossmann Sde M; Fonseca LM; Senna MI; Mesquita RA
J Oral Pathol Med; 2006 Jul; 35(6):321-6. PubMed ID: 16762011
[TBL] [Abstract][Full Text] [Related]
10. Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients.
Miziara ID; Weber R
Oral Dis; 2006 Jul; 12(4):402-7. PubMed ID: 16792726
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological and oral manifestations of HIV-positive patients in a specialized service in Brazil.
Pedreira EN; Cardoso CL; Barroso Edo C; Santos JA; Fonseca FP; Taveira LA
J Appl Oral Sci; 2008; 16(6):369-75. PubMed ID: 19082393
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population.
Bravo IM; Correnti M; Escalona L; Perrone M; Brito A; Tovar V; Rivera H
Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E33-9. PubMed ID: 16388291
[TBL] [Abstract][Full Text] [Related]
13. Oral lesions associated with HIV infection before and during the antiretroviral therapy era in Ribeirão Preto, Brazil.
Lourenço AG; Motta AC; Figueiredo LT; Machado AA; Komesu MC
J Oral Sci; 2011 Sep; 53(3):379-85. PubMed ID: 21959667
[TBL] [Abstract][Full Text] [Related]
14. Oral manifestations in HIV-infected individuals from Thailand and Cambodia.
Reichart PA; Khongkhunthian P; Bendick C
Med Microbiol Immunol; 2003 Aug; 192(3):157-60. PubMed ID: 12920591
[TBL] [Abstract][Full Text] [Related]
15. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study.
Tappuni AR; Fleming GJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Dec; 92(6):623-8. PubMed ID: 11740479
[TBL] [Abstract][Full Text] [Related]
16. Dental and oral lesions in HIV infected patients: a study in Brazil.
Pinheiro A; Marcenes W; Zakrzewska JM; Robinson PG
Int Dent J; 2004 Jun; 54(3):131-7. PubMed ID: 15218892
[TBL] [Abstract][Full Text] [Related]
17. Oral manifestations as predictors of immune suppression in a HIV-/AIDS-infected population in south India.
Sharma G; Pai KM; Setty S; Ramapuram JT; Nagpal A
Clin Oral Investig; 2009 Jun; 13(2):141-8. PubMed ID: 18668269
[TBL] [Abstract][Full Text] [Related]
18. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London.
Eyeson JD; Tenant-Flowers M; Cooper DJ; Johnson NW; Warnakulasuriya KA
J Oral Pathol Med; 2002 Mar; 31(3):169-74. PubMed ID: 11903824
[TBL] [Abstract][Full Text] [Related]
19. Sentinels and signposts: the epidemiology and significance of the oral manifestations of HIV disease.
Greenspan JS
Oral Dis; 1997 May; 3 Suppl 1():S13-7. PubMed ID: 9456650
[TBL] [Abstract][Full Text] [Related]
20. Risk indicators for HIV-associated jointly occurring oral candidiasis and oral hairy leukoplakia.
Chattopadhyay A; Patton LL
AIDS Patient Care STDS; 2007 Nov; 21(11):825-32. PubMed ID: 18240892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
